Global Sexually Transmitted Diseases (STD) Testing Market Size, Share & Industry Trends Analysis Report By Disease Type, By the Location of Testing, By Regional Outlook, Strategy, Challenges and Forecast, 2021 - 2027

The Global Sexually Transmitted Diseases (STD) Testing Market size is expected to reach $119.95 billion by 2027, rising at a market growth of 4.5% CAGR during the forecast period.

Infections transmitted from an infected person to an uninfected person through sexual intercourse are known as sexually transmitted diseases (STDs). Vaginal, oral, or anal sex are the most common forms of sexual contacts through which STDs get transmitted. Additionally, these diseases can spread through other forms of intimate physical contact also. This is due to the fact that some STDs, such as herpes and HPV, are spread through skin-to-skin contact since some of them are caused by Bacteria, viruses, or parasites. Gonorrhea, genital herpes, human papillomavirus infection, HIV/AIDS, chlamydia, and syphilis are only a few examples of STDs.

HIV/AIDS has consistently rated among the top ten leading causes of death for decades. In developed countries, testing and treatment have considerably reduced the disease's impact and prevalence. However, among younger groups, there has been a substantial increase in infection rates.

COVID-19 Impact Analysis

The COVID-19 pandemic is a public health disaster that has a negative impact on the STD testing market. Sexually transmitted infection cases were high prior to the pandemic, but following the pandemic, STD testing cases have reduced. Due to difficulties in health care and sexually transmitted infection testing services during the early months of the COVID-19 pandemic, testing reports of sexually transmitted infections were declined.

Due to a scarcity of intensive care resources, efforts were concentrated on ensuring the availability of critical care services. In addition, the imposition of restrictions like the ban on imports & exports and disruption in the supply chain have hampered the demand for STD testing kits and hence, hinder the growth of the STD testing market in the upcoming years.

Market Growth Factors:

Increasing awareness among population

There are many governments across developed and developing nations who are trying to aware people regarding the importance of early testing of STDs. For this, government and other healthcare authorities have strategized various campaigns for creating awareness among people regarding STDs. For example, CDC has initiated STD Awareness Week, which held in the second week of April. Also, many other renowned healthcare organizations are running campaigns for the same in their respective regions or even worldwide.

Rising government investments or funds

Several government authorities are increasing their investment in the development of fast and effective STD testing since it helps them to control the cases of STDs by providing correct medications at the correct time. The death rate of people having STDs is significantly high because patients do not get tested with correct measures at right time, which makes their condition more vulnerable and difficult to treat.

Marketing Restraining Factor:

Weak health services for screening and curing STDs

People seeking STI testing and treatment face numerous issues. Limited resources, poor service quality, and little or no sexual partner follow-up are among them. STI services are given independently in many countries and are not included in primary health care, family planning, or other regular health treatments. Because of a shortage of qualified employees, laboratory capacity, and adequate supply of relevant medicines, many services are unable to perform screening for asymptomatic infections.

Disease Type Outlook

Based on Disease Type, the market is segmented into Chlamydia, Herpes simplex, Gonorrhea, Syphilis, Human papillomavirus (HPV), and Other Disease. Gonorrhea segment is estimated to garner a substantial share in the market during the forecast period. The bacteria Neisseria gonorrhoeae causes gonorrhoea, which is a sexually transmitted illness (STD).

Location of Testing Outlook

Based on the Location of Testing, the market is segmented into Laboratory Testing and Point of care (POC) Testing. Point of care testing refers to the medical diagnostic testing done in the nearby care center. People who have not undergone professional laboratory training can also undertake POC testing.

Sexually Transmitted Diseases (STD) Testing Market Report Coverage

Report Attribute	Details
Market size value in 2020	USD 90.7 Billion
Market size forecast in 2027	USD 120 Billion
Base Year	2020
Historical Period	2017 to 2019
Forecast Period	2021 to 2027
Revenue Growth Rate	CAGR of 4.5% from 2021 to 2027
Number of Pages	193
Number of Tables	284
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Disease Type, Location of Testing, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Increasing awareness among population Rising government investments or funds
Restraints	Weak health services for screening and curing STDs

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia-Pacific emerged as the leading region in the sexually transmitted diseases market with the largest revenue share and is projected to continue this trend during the forecast period. This is due to an increase in the number of cases of sexually transmitted illnesses in developing countries like China and Japan.

KBV Cardinal Matrix - Sexually Transmitted Diseases (STD) Testing Market Competition Analysis

Free Valuable Insights: Global Sexually Transmitted Diseases (STD) Testing Market size to reach USD 120 Billion by 2027

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd. is the major forerunner in the Sexually Transmitted Diseases (STD) Testing Market. Companies such as Abbott Laboratories, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc. are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin Molecular LLC, Danaher Corporation, Bio-Rad Laboratories, Inc., and OraSure Technologies, Inc.

Recent Strategies Deployed in Sexually Transmitted Diseases (STD) Testing Market

» Partnerships, Collaborations and Agreements:

• Jun-2020: Roche formed a partnership with SpeeDx, a developer of innovative molecular diagnostic solutions. This partnership aimed to enable Roche Diagnostics to offer clinicians critical and advanced tools for the detection of antibiotic resistance in patients with sexually transmitted infections.
• Apr-2017: Thermo Fisher Scientific entered into a partnership with SpeeDx, a provider of innovative multiplex and isothermal amplification solutions for clinical diagnostics. This partnership aimed to get FDA clearance of the Australian developer’s ResistancePlus MG molecular diagnostic for the sexually transmitted infection, which is constantly developing into an antibiotic-resistant superbug.

» Product Launches and Product Expansions:

• Dec-2021: Becton, Dickinson, and Company (BD) expanded its BD COR System to involve the latest MX instrument for high-throughput infectious diseases testing. This accessibility of the MX instrument would expand the usage of the platform and automate testing for an expanding list of high-demand, important assays for women’s health & STI testing utilizing multiplex PCR assay design, beginning with BD’s CTGCTV2 test.
• Dec-2021: Hologic unveiled Panther Trax that presents the new addition to the Panther Scalable Solutions (PSS) portfolio of products. This product would offer advancement in lab automation by physically connecting various Panther instruments together into one, powerful work cell, which would enable labs to boost testing volumes without raising the number of staff.
• Sep-2020: Roche released the Elecsys HIV Duo immunoassay in the U.S., which has received FDA approval. By this separate measurement of the anti-HIV antibodies (caused by immune reaction) and HIV p24 antigen (the virus), this test can be used to identify an acute HIV infection prior to their existing methods.
• Oct-2019: Novosanis, a subsidiary of OraSure Technologies released two variants of its urine-capturing device, Colli-Pee. The latest variants enable the collection of smaller and bigger amounts of first-void urine in comparison to the original 20 mL device, which would provide additional applications in the area of uro-oncology, infectious disease, and beyond.

» Acquisitions and Mergers:

• Mar-2021: Hologic took over Diagenode, a privately held, European developer and manufacturer of molecular diagnostic assays and epigenetics products. This acquisition aimed to strengthen its molecular diagnostics business by expanding its international capabilities, enhancing its regional time-to-market, and enabling the company to provide a wider, more differentiated test menu.
• Feb-2020: Bio-Rad Laboratories acquired Exact Diagnostics, developer of various diagnostic products. This acquisition aimed to access a complete catalog of molecular quality control products in the field of respiratory, transplant, virology, sexually transmitted infections, microbiology, and vector-borne diseases.
• Jan-2019: OraSure Technologies completed the acquisition of Novosanis, a privately-held, Belgian company. The acquisition aimed to represent a clear fit in its stated ‘core growth strategy for the Molecular business in order to expand its portfolio of collection products beyond oral samples by leveraging its expertise in stabilization and collection tools & technologies, which is utilized at home or in the clinic.

» Approvals and Trials:

• May-2019: Hologic got the FDA clearance for its new Aptima BV and Aptima CV/TV assays. This clearance would offer a precise and objective way for diagnosing vaginitis, which is a very common and complicated health issue affecting millions of women every year.
• Mar-2019: Abbott received CE Mark for its Alinity m diagnostics system and assays. This latest technology would assist in keeping up with the rising demand for infectious disease testing. Alinity m provides initial assays that include virologic testing for human immunodeficiency virus type 1 (HIV-1), sexual health-related testing for Chlamydia trachomatis, Trichomonas vaginalis, Neisseria gonorrhoeae, and Mycoplasma genitalium or CT/NG/TV/MG panel; hepatitis B virus (HBV) and hepatitis C virus (HCV); and high-risk human papillomavirus (HPV) testing.
• Jan-2019: Hologic received clearance from the U.S. Food and Drug Administration (FDA) for its Aptima Mycoplasma genitalium assay. This essay is the first and only FDA-cleared test to identify the under-recognized as well as highly common sexually transmitted infection (STI). The launch of the Aptima Mycoplasma genitalium assay would provide healthcare professionals the opportunity to offer optimal care for their patients and support Hologic’s mission to develop advanced solutions that fulfill the emerging public health threats.

Scope of the Study

Market Segments Covered in the Report:

By Disease Type

• Chlamydia
• Herpes simplex
• Gonorrhea
• Syphilis 
• Human papillomavirus (HPV)
• Other Disease

By Location of Testing

• Laboratory Testing
• Point of care (POC) Testing

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• BioMérieux S.A.
• Abbott Laboratories
• Becton, Dickinson and Company
• Hologic, Inc.
• Thermo Fisher Scientific, Inc.
• F. Hoffmann-La Roche Ltd.
• DiaSorin Molecular LLC
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• OraSure Technologies, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Sexually Transmitted Diseases (STD) Testing Market, by Disease Type
1.4.2 Global Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing
1.4.3 Global Sexually Transmitted Diseases (STD) Testing Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Oct – 2021, Dec) Leading Players

Chapter 4. Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type
4.1 Global Chlamydia Market by Region
4.2 Global Herpes simplex virus Market by Region
4.3 Global Gonorrhea Market by Region
4.4 Global Syphilis Market by Region
4.5 Global Human papillomavirus (HPV) Market by Region
4.6 Global Other Disease Market by Region

Chapter 5. Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
5.1 Global Laboratory Testing Market by Region
5.2 Global Point of care (POC) Testing Market by Region

Chapter 6. Global Sexually Transmitted Diseases (STD) Testing Market by Region
6.1 North America Sexually Transmitted Diseases (STD) Testing Market
6.1.1 North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.1.1 North America Chlamydia Market by Country
6.1.1.2 North America Herpes simplex virus Market by Country
6.1.1.3 North America Gonorrhea Market by Country
6.1.1.4 North America Syphilis Market by Country
6.1.1.5 North America Human papillomavirus (HPV) Market by Country
6.1.1.6 North America Other Disease Market by Country
6.1.2 North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.1.2.1 North America Laboratory Testing Market by Country
6.1.2.2 North America Point of care (POC) Testing Market by Country
6.1.3 North America Sexually Transmitted Diseases (STD) Testing Market by Country
6.1.3.1 US Sexually Transmitted Diseases (STD) Testing Market
6.1.3.1.1 US Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.3.1.2 US Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.1.3.2 Canada Sexually Transmitted Diseases (STD) Testing Market
6.1.3.2.1 Canada Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.3.2.2 Canada Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.1.3.3 Mexico Sexually Transmitted Diseases (STD) Testing Market
6.1.3.3.1 Mexico Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.3.3.2 Mexico Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.1.3.4 Rest of North America Sexually Transmitted Diseases (STD) Testing Market
6.1.3.4.1 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.3.4.2 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2 Europe Sexually Transmitted Diseases (STD) Testing Market
6.2.1 Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.1.1 Europe Chlamydia Market by Country
6.2.1.2 Europe Herpes simplex virus Market by Country
6.2.1.3 Europe Gonorrhea Market by Country
6.2.1.4 Europe Syphilis Market by Country
6.2.1.5 Europe Human papillomavirus (HPV) Market by Country
6.2.1.6 Europe Other Disease Market by Country
6.2.2 Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.2.1 Europe Laboratory Testing Market by Country
6.2.2.2 Europe Point of care (POC) Testing Market by Country
6.2.3 Europe Sexually Transmitted Diseases (STD) Testing Market by Country
6.2.3.1 Germany Sexually Transmitted Diseases (STD) Testing Market
6.2.3.1.1 Germany Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.1.2 Germany Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.2 UK Sexually Transmitted Diseases (STD) Testing Market
6.2.3.2.1 UK Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.2.2 UK Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.3 France Sexually Transmitted Diseases (STD) Testing Market
6.2.3.3.1 France Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.3.2 France Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.4 Russia Sexually Transmitted Diseases (STD) Testing Market
6.2.3.4.1 Russia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.4.2 Russia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.5 Spain Sexually Transmitted Diseases (STD) Testing Market
6.2.3.5.1 Spain Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.5.2 Spain Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.6 Italy Sexually Transmitted Diseases (STD) Testing Market
6.2.3.6.1 Italy Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.6.2 Italy Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.7 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market
6.2.3.7.1 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.7.2 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
6.3.1 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.1.1 Asia Pacific Chlamydia Market by Country
6.3.1.2 Asia Pacific Herpes simplex virus Market by Country
6.3.1.3 Asia Pacific Gonorrhea Market by Country
6.3.1.4 Asia Pacific Syphilis Market by Country
6.3.1.5 Asia Pacific Human papillomavirus (HPV) Market by Country
6.3.1.6 Asia Pacific Other Disease Market by Country
6.3.2 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.2.1 Asia Pacific Laboratory Testing Market by Country
6.3.2.2 Asia Pacific Point of care (POC) Testing Market by Country
6.3.3 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country
6.3.3.1 China Sexually Transmitted Diseases (STD) Testing Market
6.3.3.1.1 China Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.1.2 China Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.2 Japan Sexually Transmitted Diseases (STD) Testing Market
6.3.3.2.1 Japan Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.2.2 Japan Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.3 India Sexually Transmitted Diseases (STD) Testing Market
6.3.3.3.1 India Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.3.2 India Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.4 South Korea Sexually Transmitted Diseases (STD) Testing Market
6.3.3.4.1 South Korea Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.4.2 South Korea Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.5 Singapore Sexually Transmitted Diseases (STD) Testing Market
6.3.3.5.1 Singapore Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.5.2 Singapore Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.6 Malaysia Sexually Transmitted Diseases (STD) Testing Market
6.3.3.6.1 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.6.2 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.7 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
6.3.3.7.1 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.7.2 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4 LAMEA Sexually Transmitted Diseases (STD) Testing Market
6.4.1 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.1.1 LAMEA Chlamydia Market by Country
6.4.1.2 LAMEA Herpes simplex virus Market by Country
6.4.1.3 LAMEA Gonorrhea Market by Country
6.4.1.4 LAMEA Syphilis Market by Country
6.4.1.5 LAMEA Human papillomavirus (HPV) Market by Country
6.4.1.6 LAMEA Other Disease Market by Country
6.4.2 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.2.1 LAMEA Laboratory Testing Market by Country
6.4.2.2 LAMEA Point of care (POC) Testing Market by Country
6.4.3 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country
6.4.3.1 Brazil Sexually Transmitted Diseases (STD) Testing Market
6.4.3.1.1 Brazil Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.1.2 Brazil Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.2 Argentina Sexually Transmitted Diseases (STD) Testing Market
6.4.3.2.1 Argentina Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.2.2 Argentina Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.3 UAE Sexually Transmitted Diseases (STD) Testing Market
6.4.3.3.1 UAE Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.3.2 UAE Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.4 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market
6.4.3.4.1 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.4.2 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.5 South Africa Sexually Transmitted Diseases (STD) Testing Market
6.4.3.5.1 South Africa Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.5.2 South Africa Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.6 Nigeria Sexually Transmitted Diseases (STD) Testing Market
6.4.3.6.1 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.6.2 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.7 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market
6.4.3.7.1 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.7.2 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing

Chapter 7. Company Profiles
7.1 BioMérieux S.A.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.3 Becton, Dickinson and Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Hologic, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.6 SWOT Analysis
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Product Launches and Product Expansions:
7.7 DiaSorin Molecular LLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Danaher Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bio-Rad laboratories, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. OraSure Technologies, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional & Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
7.10.5.2 Acquisition and Mergers:

TABLE 1 Global Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 2 Global Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Sexually Transmitted Diseases (STD) Testing Market
TABLE 4 Product Launches And Product Expansions– Sexually Transmitted Diseases (STD) Testing Market
TABLE 5 Acquisition and Mergers– Sexually Transmitted Diseases (STD) Testing Market
TABLE 6 approvals and trials– Sexually Transmitted Diseases (STD) Testing Market
TABLE 7 Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 8 Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 9 Global Chlamydia Market by Region, 2017 - 2020, USD Million
TABLE 10 Global Chlamydia Market by Region, 2021 - 2027, USD Million
TABLE 11 Global Herpes simplex virus Market by Region, 2017 - 2020, USD Million
TABLE 12 Global Herpes simplex virus Market by Region, 2021 - 2027, USD Million
TABLE 13 Global Gonorrhea Market by Region, 2017 - 2020, USD Million
TABLE 14 Global Gonorrhea Market by Region, 2021 - 2027, USD Million
TABLE 15 Global Syphilis Market by Region, 2017 - 2020, USD Million
TABLE 16 Global Syphilis Market by Region, 2021 - 2027, USD Million
TABLE 17 Global Human papillomavirus (HPV) Market by Region, 2017 - 2020, USD Million
TABLE 18 Global Human papillomavirus (HPV) Market by Region, 2021 - 2027, USD Million
TABLE 19 Global Other Disease Market by Region, 2017 - 2020, USD Million
TABLE 20 Global Other Disease Market by Region, 2021 - 2027, USD Million
TABLE 21 Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 22 Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 23 Global Laboratory Testing Market by Region, 2017 - 2020, USD Million
TABLE 24 Global Laboratory Testing Market by Region, 2021 - 2027, USD Million
TABLE 25 Global Point of care (POC) Testing Market by Region, 2017 - 2020, USD Million
TABLE 26 Global Point of care (POC) Testing Market by Region, 2021 - 2027, USD Million
TABLE 27 Global Sexually Transmitted Diseases (STD) Testing Market by Region, 2017 - 2020, USD Million
TABLE 28 Global Sexually Transmitted Diseases (STD) Testing Market by Region, 2021 - 2027, USD Million
TABLE 29 North America Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 30 North America Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 31 North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 32 North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 33 North America Chlamydia Market by Country, 2017 - 2020, USD Million
TABLE 34 North America Chlamydia Market by Country, 2021 - 2027, USD Million
TABLE 35 North America Herpes simplex virus Market by Country, 2017 - 2020, USD Million
TABLE 36 North America Herpes simplex virus Market by Country, 2021 - 2027, USD Million
TABLE 37 North America Gonorrhea Market by Country, 2017 - 2020, USD Million
TABLE 38 North America Gonorrhea Market by Country, 2021 - 2027, USD Million
TABLE 39 North America Syphilis Market by Country, 2017 - 2020, USD Million
TABLE 40 North America Syphilis Market by Country, 2021 - 2027, USD Million
TABLE 41 North America Human papillomavirus (HPV) Market by Country, 2017 - 2020, USD Million
TABLE 42 North America Human papillomavirus (HPV) Market by Country, 2021 - 2027, USD Million
TABLE 43 North America Other Disease Market by Country, 2017 - 2020, USD Million
TABLE 44 North America Other Disease Market by Country, 2021 - 2027, USD Million
TABLE 45 North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 46 North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 47 North America Laboratory Testing Market by Country, 2017 - 2020, USD Million
TABLE 48 North America Laboratory Testing Market by Country, 2021 - 2027, USD Million
TABLE 49 North America Point of care (POC) Testing Market by Country, 2017 - 2020, USD Million
TABLE 50 North America Point of care (POC) Testing Market by Country, 2021 - 2027, USD Million
TABLE 51 North America Sexually Transmitted Diseases (STD) Testing Market by Country, 2017 - 2020, USD Million
TABLE 52 North America Sexually Transmitted Diseases (STD) Testing Market by Country, 2021 - 2027, USD Million
TABLE 53 US Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 54 US Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 55 US Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 56 US Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 57 US Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 58 US Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 59 Canada Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 60 Canada Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 61 Canada Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 62 Canada Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 63 Canada Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 64 Canada Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 65 Mexico Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 66 Mexico Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 67 Mexico Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 68 Mexico Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 69 Mexico Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 70 Mexico Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 71 Rest of North America Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 72 Rest of North America Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 73 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 74 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 75 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 76 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 77 Europe Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 78 Europe Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 79 Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 80 Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 81 Europe Chlamydia Market by Country, 2017 - 2020, USD Million
TABLE 82 Europe Chlamydia Market by Country, 2021 - 2027, USD Million
TABLE 83 Europe Herpes simplex virus Market by Country, 2017 - 2020, USD Million
TABLE 84 Europe Herpes simplex virus Market by Country, 2021 - 2027, USD Million
TABLE 85 Europe Gonorrhea Market by Country, 2017 - 2020, USD Million
TABLE 86 Europe Gonorrhea Market by Country, 2021 - 2027, USD Million
TABLE 87 Europe Syphilis Market by Country, 2017 - 2020, USD Million
TABLE 88 Europe Syphilis Market by Country, 2021 - 2027, USD Million
TABLE 89 Europe Human papillomavirus (HPV) Market by Country, 2017 - 2020, USD Million
TABLE 90 Europe Human papillomavirus (HPV) Market by Country, 2021 - 2027, USD Million
TABLE 91 Europe Other Disease Market by Country, 2017 - 2020, USD Million
TABLE 92 Europe Other Disease Market by Country, 2021 - 2027, USD Million
TABLE 93 Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 94 Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 95 Europe Laboratory Testing Market by Country, 2017 - 2020, USD Million
TABLE 96 Europe Laboratory Testing Market by Country, 2021 - 2027, USD Million
TABLE 97 Europe Point of care (POC) Testing Market by Country, 2017 - 2020, USD Million
TABLE 98 Europe Point of care (POC) Testing Market by Country, 2021 - 2027, USD Million
TABLE 99 Europe Sexually Transmitted Diseases (STD) Testing Market by Country, 2017 - 2020, USD Million
TABLE 100 Europe Sexually Transmitted Diseases (STD) Testing Market by Country, 2021 - 2027, USD Million
TABLE 101 Germany Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 102 Germany Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 103 Germany Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 104 Germany Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 105 Germany Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 106 Germany Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 107 UK Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 108 UK Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 109 UK Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 110 UK Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 111 UK Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 112 UK Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 113 France Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 114 France Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 115 France Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 116 France Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 117 France Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 118 France Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 119 Russia Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 120 Russia Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 121 Russia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 122 Russia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 123 Russia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 124 Russia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 125 Spain Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 126 Spain Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 127 Spain Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 128 Spain Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 129 Spain Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 130 Spain Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 131 Italy Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 132 Italy Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 133 Italy Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 134 Italy Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 135 Italy Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 136 Italy Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 137 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 138 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 139 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 140 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 141 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 142 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 143 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 144 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 145 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 146 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 147 Asia Pacific Chlamydia Market by Country, 2017 - 2020, USD Million
TABLE 148 Asia Pacific Chlamydia Market by Country, 2021 - 2027, USD Million
TABLE 149 Asia Pacific Herpes simplex virus Market by Country, 2017 - 2020, USD Million
TABLE 150 Asia Pacific Herpes simplex virus Market by Country, 2021 - 2027, USD Million
TABLE 151 Asia Pacific Gonorrhea Market by Country, 2017 - 2020, USD Million
TABLE 152 Asia Pacific Gonorrhea Market by Country, 2021 - 2027, USD Million
TABLE 153 Asia Pacific Syphilis Market by Country, 2017 - 2020, USD Million
TABLE 154 Asia Pacific Syphilis Market by Country, 2021 - 2027, USD Million
TABLE 155 Asia Pacific Human papillomavirus (HPV) Market by Country, 2017 - 2020, USD Million
TABLE 156 Asia Pacific Human papillomavirus (HPV) Market by Country, 2021 - 2027, USD Million
TABLE 157 Asia Pacific Other Disease Market by Country, 2017 - 2020, USD Million
TABLE 158 Asia Pacific Other Disease Market by Country, 2021 - 2027, USD Million
TABLE 159 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 160 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 161 Asia Pacific Laboratory Testing Market by Country, 2017 - 2020, USD Million
TABLE 162 Asia Pacific Laboratory Testing Market by Country, 2021 - 2027, USD Million
TABLE 163 Asia Pacific Point of care (POC) Testing Market by Country, 2017 - 2020, USD Million
TABLE 164 Asia Pacific Point of care (POC) Testing Market by Country, 2021 - 2027, USD Million
TABLE 165 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country, 2017 - 2020, USD Million
TABLE 166 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country, 2021 - 2027, USD Million
TABLE 167 China Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 168 China Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 169 China Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 170 China Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 171 China Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 172 China Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 173 Japan Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 174 Japan Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 175 Japan Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 176 Japan Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 177 Japan Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 178 Japan Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 179 India Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 180 India Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 181 India Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 182 India Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 183 India Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 184 India Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 185 South Korea Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 186 South Korea Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 187 South Korea Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 188 South Korea Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 189 South Korea Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 190 South Korea Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 191 Singapore Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 192 Singapore Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 193 Singapore Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 194 Singapore Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 195 Singapore Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 196 Singapore Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 197 Malaysia Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 198 Malaysia Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 199 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 200 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 201 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 202 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 203 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 204 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 205 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 206 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 207 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 208 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 209 LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 210 LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 211 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 212 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 213 LAMEA Chlamydia Market by Country, 2017 - 2020, USD Million
TABLE 214 LAMEA Chlamydia Market by Country, 2021 - 2027, USD Million
TABLE 215 LAMEA Herpes simplex virus Market by Country, 2017 - 2020, USD Million
TABLE 216 LAMEA Herpes simplex virus Market by Country, 2021 - 2027, USD Million
TABLE 217 LAMEA Gonorrhea Market by Country, 2017 - 2020, USD Million
TABLE 218 LAMEA Gonorrhea Market by Country, 2021 - 2027, USD Million
TABLE 219 LAMEA Syphilis Market by Country, 2017 - 2020, USD Million
TABLE 220 LAMEA Syphilis Market by Country, 2021 - 2027, USD Million
TABLE 221 LAMEA Human papillomavirus (HPV) Market by Country, 2017 - 2020, USD Million
TABLE 222 LAMEA Human papillomavirus (HPV) Market by Country, 2021 - 2027, USD Million
TABLE 223 LAMEA Other Disease Market by Country, 2017 - 2020, USD Million
TABLE 224 LAMEA Other Disease Market by Country, 2021 - 2027, USD Million
TABLE 225 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 226 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 227 LAMEA Laboratory Testing Market by Country, 2017 - 2020, USD Million
TABLE 228 LAMEA Laboratory Testing Market by Country, 2021 - 2027, USD Million
TABLE 229 LAMEA Point of care (POC) Testing Market by Country, 2017 - 2020, USD Million
TABLE 230 LAMEA Point of care (POC) Testing Market by Country, 2021 - 2027, USD Million
TABLE 231 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country, 2017 - 2020, USD Million
TABLE 232 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country, 2021 - 2027, USD Million
TABLE 233 Brazil Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 234 Brazil Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 235 Brazil Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 236 Brazil Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 237 Brazil Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 238 Brazil Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 239 Argentina Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 240 Argentina Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 241 Argentina Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 242 Argentina Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 243 Argentina Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 244 Argentina Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 245 UAE Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 246 UAE Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 247 UAE Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 248 UAE Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 249 UAE Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 250 UAE Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 251 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 252 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 253 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 254 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 255 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 256 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 257 South Africa Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 258 South Africa Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 259 South Africa Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 260 South Africa Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 261 South Africa Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 262 South Africa Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 263 Nigeria Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 264 Nigeria Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 265 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 266 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 267 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 268 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 269 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2017 - 2020, USD Million
TABLE 270 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market, 2021 - 2027, USD Million
TABLE 271 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2017 - 2020, USD Million
TABLE 272 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type, 2021 - 2027, USD Million
TABLE 273 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2017 - 2020, USD Million
TABLE 274 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing, 2021 - 2027, USD Million
TABLE 275 Key information – BioMérieux S.A.
TABLE 276 Key Information – Abbott Laboratories
TABLE 277 Key information – Becton, Dickinson and Company
TABLE 278 Key information – Hologic, Inc.
TABLE 279 Key Information – Thermo Fisher Scientific, Inc.
TABLE 280 key information – F. Hoffmann-La Roche Ltd.
TABLE 281 Key information – DiaSorin Molecular LLC
TABLE 282 Key Information – Danaher Corporation
TABLE 283 Key Information – Bio-Rad Laboratories, Inc.
TABLE 284 Key information – OraSure Technologies, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 1 KBV Cardinal Matrix
FIG 2 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 3 Key Strategic Move: (Product Launches and Product Expansions : 2019, Oct – 2021, dec) Leading Players
FIG 4 Recent strategies and developments: Hologic, Inc.
FIG 5 Swot analysis: thermo fisher scientific, inc.
FIG 6 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 7 Recent strategies and developments: OraSure Technologies, Inc.